A new Alzheimer’s blood test recently approved by the U. S. Food and Drug Administration (FDA) can now detect the disease in people with early stages of the illness. The research that led to the finding was published in Friday’s edition of Alzheimer’s and Dementia: The Journal of the Alzheimer’s Association.
